El Butlletí de la Recerca es fa ressò de les publicacions indexades a la Web of Science i a Scopus, però també podeu fer-nos arribar les vostres publicacions a través de l’URecerca – Gestió de la Producció Científica que trobareu al Campus Virtual.
Current Trends and Future Directions in Urban Social Prescribing
Litt, J. S., Coll-Planas, L., Sachs, A. L., Masó Aguado, M., & Howarth, M. (2023). Current Trends and Future Directions … Read More
A Meta-Review to Guide Military Screening and Treatment of Gambling Problems
Segura, A., Heyman, R. E., Ochshorn, J., & Slep, A. M. S. (2023). A Meta-Review to Guide Military Screening and … Read More
STELLAR-303: A phase 3 study of XL092 in combination with atezolizumab versus regorafenib in patients with previously treated metastatic colorectal cancer (mCRC)
Hecht, J. R., Tabernero, J., Parikh, A. R., Wang, Y. J., Wang, Z., Schwickart, M., . . . Saeed, A. … Read More
Impact of Lynch syndrome, BRAFV600E, and RAS mutations on outcomes in MSI/dMMR metastatic colorectal cancer (mCRC) treated with immune checkpoint inhibitors (ICI): Analysis of combined international cohorts
Colle, R., Lonardi, S., Cachanado, M., Overman, M. J., Elez, E., Fakih, M., . . . Andre, T. (2023). Impact … Read More
BREAKWATER safety lead-in (SLI): Encorafenib (E) plus cetuximab (C) plus chemotherapy for BRAFV600E metastatic colorectal cancer (mCRC)
Kopetz, S., Yoshino, T., Kim, T. W., Yaeger, R., Desai, J., Wasan, H. S., . . . Tabernero, J. (2023). … Read More
Trifluridine/tipiracil plus bevacizumab for third-line treatment of refractory metastatic colorectal cancer: The phase 3 randomized SUNLIGHT study
Tabernero, J., Prager, G. W., Fakih, M., Ciardiello, F., Van Cutsem, E., Elez, E., . . . Taieb, J. (2023). … Read More
Gene expression profiling in tumors with and without tertiary lymphoid structures across cancer-types
Solis, E. S., Pascual, T., Torres, E. S., Gonzalez-Farre, B., Brasó-Maristany, F., Farre, X. G., . . . Tabernero, J., … Read More
Pembrolizumab plus trastuzumab and chemotherapy for HER2+metastatic gastric or gastroesophageal junction (mG/ GEJ) adenocarcinoma: Survival results from the phase III, randomized, double-blind, placebo-controlled KEYNOTE-811 study
Janjigian, Y. Y., Kawazoe, A., Bai, Y., Xu, J., Lonardi, S., Metges, J. P., . . . Tabernero, J., Rha, … Read More
Pathological complete response (pCR) to durvalumab plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in resectable gastric and gastroesophageal junction cancer (GC/GEJC): Interim results of the global, phase III MATTERHORN study
Janjigian, Y. Y., Al-Batran, S. E., Wainberg, Z. A., Van Cutsem, E., Molena, D., Muro, K., . . . Tabernero, … Read More
Identification and external validation of clinical-molecular features to predict benefit from oxaliplatin reintroduction/rechallenge in patients with refractory metastatic colorectal cancer (mCRC)
Salva, F., Paes, R., Silva, M. C. E., Cruz, H., Gonzalez, N. S., Baraibar, I., . . . Tabernero, J., … Read More
A cross-sectional study to ascertain malaria prevalence among asymptomatic travellers arriving on the Lihir Group of Islands, Papua New Guinea: implications for elimination efforts
Millat-Martínez, P., Baro, B., Kasian, B., Lorry, L., Sanz, S., Wali, C., . . . Mitjà, O., Bassat, Q. (2023). … Read More
What is bad for the heart is bad for the brain?
Sangüesa, G., Batlle, M., & Guasch, E. (2023). What is bad for the heart is bad for the brain? Heart … Read More
Diabetic microvascular disease in non-classical beds: The hidden impact beyond the retina, the kidney, and the peripheral nerves
Mauricio, D., Gratacòs, M., & Franch-Nadal, J. (2023). Diabetic microvascular disease in non-classical beds: The hidden impact beyond the retina, … Read More
Effect of Foot Orthoses on Angular Velocity of Feet
Florenciano Restoy, J. L., Solé-Casals, J., Borràs-Boix, X. (2023). Effect of Foot Orthoses on Angular Velocity of Feet. Sensors (Basel, … Read More
SEAMARK: Randomized phase 2 study of pembrolizumab plus encorafenib plus cetuximab vs pembrolizumab alone for first-line treatment of BRAF V600E-mutant microsatellite instability-high (MSI-H)/mismatch repair deficient (dMMR) metastatic colorectal cancer (CRC)
Kopetz, S., Bekaii-Saab, T. S., Yoshino, T., Chung, C. H., Zhang, X. S., Tabernero, J. (2023). SEAMARK: Randomized phase 2 … Read More
Automatic shoreline detection by processing planview timex images using bi-LSTM networks
Marti-Puig, P., Serra-Serra, M., Ribas, F., Simarro, G., & Caballeria, M. (2024). Automatic shoreline detection by processing planview timex images … Read More
Sexual dysfunction in women with breast cancer of Northeast Brazil: A retrospective longitudinal study
Sousa Rodrigues Guedes, T., Barbosa Otoni Gonçalves Guedes, M., Mikael Lopes, J., de Castro Santana, R., Borba de Vasconcelos, J., … Read More
Time to start testing KRAS and BRAF V600E mutations in stage III colon cancer? Not in routine care, yet in clinical trials
Dienstmann, R. (2023). Time to start testing KRAS and BRAF V600E mutations in stage III colon cancer? Not in routine … Read More